Assessment of the metabolic profile in Type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy

Magnetic Resonance Imaging

Volumn 26, Issue 3, 2008, Pages 420-425

  Modi, Shilpi ^a   Bhattacharya, Manisha ^a   Sekhri, Tarun ^a   Rana, Poonam ^a   Tripathi, Rajendra P ^a   Khushu, Subash ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Diabetes mellitus; Hypothyroidism; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; PHOSPHOLIPID;

ADULT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; HYPOTHYROIDISM; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADULT; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOTHYROIDISM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 40049091968     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2007.08.011     Document Type: Article

References (34)

1. 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 4 (1991) 47-52
2. Demougeot C., Garnier P., Mossiat C., Bertrand N., Giroud M., Beley A., et al. N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 77 (2001) 408-415
3. Puri B.K. Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia. Int Rev Psychiatry 8 (2006) 145-147
4. Bhatara V.S., Tripathi R.P., Sankar R., Gupta A., and Khushu S. Frontal lobe proton magnetic resonance spectroscopy in Graves' disease: a pilot study. Psychoneuroendocrinology 23 (1998) 605-612
5. Elberling T.V., Danielson E.R., Rasmussen A.K., Feldt-Rasmussen U., Waldemar G., and Thomsen C. Reduced myo-inositol and total choline measured with cerebral MRS in acute thyrotoxic Grave's disease. Neurology 60 (2003) 142-145
6. Gupta R.K., Bhatia V., Poptani H., and Gujral R.B. Brain metabolite changes on in vivo proton magnetic resonance spectroscopy in children with congenital hypothyroidism. J Pediatr 126 (1995) 389-392
7. Smith C., and Ain K. Brain metabolism in hypothyroidism studied with 31P magnetic resonance spectroscopy. Lancet 345 (1995) 619-620
8. Meyerhoff D.J., Blumenfeld R., Truran D., Lindgren J., Flenniken D., Cardenas V., et al. Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites. Alcohol Clin Exp Res 28 (2004) 650-651
9. Jagannathan N.R., Desai N.G., and Raghunathan P. Brain metabolite changes in alcoholism: an in vivo proton magnetic resonance spectroscopy (MRS) study. Magn Reson Imaging 14 (1996) 553-557
10. Schweinsburg B.C., Alhassoon O.M., Taylor M.J., Gonzalez R., Videen J.S., Brown G.G., et al. Effects of alcoholism and gender on brain metabolism. Am J Psychiatry 160 (2003) 1180-1183
11. Modi S., Bhattacharya M., Kumar P., Naik A., Bhatia T., Deshpande S.N., et al. Assessment of the metabolic profile in alcohol dependents through proton MR spectroscopy. Book of abstracts: current trends in solid state NMR methodology and practice and 13th NMRS meeting (2007), Pune, India 148
12. Bustillo J.R., Rowland L.M., Lauriello J., Petropoulos H., Hammond R., Hart B., et al. High choline concentrations in the caudate nucleus in antipsychotic-naïve patients with schizophrenia. Am J Psychiatry 159 (2002) 130-133
13. Sarac K., Akinci A., Alkan A., Aslan M., Baysal T., and Ozcan C. Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology 47 (2005) 562-565
14. Geissler A., Frund R., Scholmerich J., Feuerbach S., and Zietz B. Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp Clin Endocrinol Diabetes 111 (2003) 421-427
15. Kreis R., and Ross B.D. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 184 (1992) 123-130
16. Biessels G.J., Kappelle A.C., Bravenboer B., Erkelens D.W., and Gispen W.H. Cerebral function in diabetes mellitus. Diabetologia 37 (1994) 643-650
17. Scheuermann-Freestone M., Madsen P.L., Blamire A.M., Buckingham R.E., Styles P., Radda G.K., et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107 (2003) 3040-3046
18. Brands A.M., Kessels R.P., de Haan E.H., Kappelle L.J., and Biessels GJ. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Eur J Pharmacol 490 (2004) 159-168
19. Awad N., Gagnon M., and Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 26 (2004) 1044-1080
20. Telushkin P.K., and Nozdrachev A.D. Hypoglycemia and the brain: metabolism and the mechanisms of neuronal damage. Usp Fiziol Nauk 30 (1999) 14-27
21. Harati Y. Diabetes and the nervous system. Endocrinol Metab Clin North Am 25 (1996) 325-359
22. Vincent A.M., Brownlee M., and Russell J.W. Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci 959 (2002) 368-383
23. 1H magnetic resonance spectroscopy. NMR Biomed 17 (2004) 405-410
24. Jagannathan N.R., Tandon N., Raghunathan P., and Kochupillai N. Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study. Brain Res Dev Brain Res 109 (1998) 179-186
25. Williams S.R. In vivo proton spectroscopy: experimental aspects and potential. In: Rudin M. (Ed). NMR basic principles and progress vol 28 (1992), Springer, Berlin 55-71
26. Djuricic B., Olson S.R., Assaf H.M., Whittingham T.S., Lust W.D., and Drewes L.R. Formation of free choline in brain tissue during in vitro energy deprivation. J Cereb Blood Flow Metab 11 (1991) 308-313
27. Zeisel S.H. Formation of unesterified choline by rat brain. Biochim Biophys Acta 835 (1985) 331-343
28. Qian Z., and Drewes L.R. Muscarinic acetylcholine receptor regulates phosphatidylcholine phospholipase D in canine brain. J Biol Chem 264 (1989) 21720-21724
29. Hattori H., and Kanfer J.N. Synaptosomal phospholipase D potential role in providing choline for acetylcholine synthesis. J Neurochem 45 (1985) 1578-1584
30. Deutsh G., Papanicolaou A., Bourbon W., and Eisenberg H. Cerebral flow evidence of right frontal lobe activation in attention demanding tasks. Int J Neurosci 36 (1987) 23-28
31. Ernst M. Neuroimaging in attention-deficit/hyperactivity disorder. In: Lyon G.R., and Rumsey J.M. (Eds). Neuroimaging: a window to the neurological foundations of learning and behaviour in children (1996), Brookes, Baltimore 95-117
32. Foster J., Eskes G., and Stuss D. The cognitive neuropsychology of attention: a frontal lobe perspective. Cogn Neuropsychol 11 (1994) 133-148
33. Ajilore O., Haroon E., Kumaran S., Darwin C., Binesh N., Mintz J., et al. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology 32 (2007) 1224-1231
34. Makimattila S., Malmberg-Ceder K., Hakkinen A.M., Vuori K., Salonen O., Summanen P., et al. Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab 24 (2004) 1393-1399